VistaPharm, Inc.

Form 483 issued September 2, 2022 · Largo, Florida

Inspection
Aug 25 – Sep 2, 2022
Observations
3
Pages
4
FEI number
1036352

In short: On September 2, 2022, FDA issued a Form 483 with 3 observations to VistaPharm, Inc. in Largo, Florida (FEI 1036352) after an inspection that ran Aug 25 – Sep 2, 2022. The investigators were Damaris Y. Hernandez, Nicole E. Knowlton and Steven A. Brettler. Most observations concern production and facilities & equipment.

At a glance

Production and facilities & equipment account for 2 of 3 observations.

Production1
Facilities & equipment1
Quality system1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Your firm failed to establish adequate written procedures for production and process controls designed to assure…

  2. 02

    Buildings used in the manufacture, processing, packing or holding of drug products are not free of…

  3. 03

    The responsibilities and procedures applicable to the quality control unit…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at VistaPharm, Inc.?

FDA listed 3 observations on this Form 483, mostly about production, facilities & equipment and quality system. The opening words of each observation are shown on this page.

Who inspected VistaPharm, Inc.?

Damaris Y. Hernandez, Nicole E. Knowlton and Steven A. Brettler are named on this Form 483, for the inspection of Aug 25 – Sep 2, 2022. Each investigator has a profile showing what they cite most.

When was VistaPharm, Inc. inspected by FDA?

The inspection ran Aug 25 – Sep 2, 2022, and the Form 483 is dated September 2, 2022.

How do I get the full Form 483 for VistaPharm, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free